Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
about
Infections caused by Scedosporium spp.Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.Voriconazole in the management of nosocomial invasive fungal infections.Mycetoma medical therapy.Pseudallescheriasis in the 21st century.Treatment of scedosporiosis with voriconazole: clinical experience with 107 patientsDevelopment and validation of a quantitative PCR assay for diagnosis of scedosporiosis.Animal models: an important tool in mycology.Synthesis, Characterization, and Anti-Cancer Activity of Some New N'-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives.Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.Antifungal susceptibilities of the species of the Pseudallescheria boydii complexAntifungal effects of palmitic acid salt and ultrapure soft water on Scedosporium apiospermum.Experimental murine scedosporiosis: histopathology and azole treatment.Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.Scedosporium apiospermum Mycetoma in an Immunocompetent Patient without Prior Lung Disease.
P2860
Q24657691-896B3979-3211-49DC-8D16-2748934CE92CQ28315344-3CD06540-5369-4500-B8B6-73578B973C18Q33824506-6CC10A71-4005-4570-A299-2287A4BA5572Q33938075-4BB6C501-8322-47B8-B9D8-70166660B760Q35166823-B0F35078-F26A-4E55-9616-FF81D8ABFBE8Q35351362-96F5570C-0956-493F-9A4D-12236CCC6D5AQ36278064-A75AE8FB-92C5-4002-BBC6-88E2BAD9FBA3Q36593781-939CB1F2-4BB5-4EBC-97FC-2B70DD0C5F8EQ36933405-C195EE50-5C99-4B9B-AFF4-8F6C114F0F4CQ37008692-F92C0DE5-9A28-4205-82CA-16A6F8CD74D4Q38546970-C5244652-5CED-42D7-8C8C-A989E0361171Q40165489-37928462-54A6-477D-AD3E-F7DDF5EEEE5CQ40392406-963EE17D-8967-4EB0-BD56-2E151F4C9E3EQ40667866-11E7576B-E806-4BBD-A909-187A280D3153Q40903665-84C3D5C9-A6B2-4FDE-9F79-BD40D4CB3017Q42256356-3FCE00AF-4E3F-4EE8-B4C5-48603F680F53Q42430220-79FCCE6C-5E45-4B54-ABD3-6C83B51D1B5DQ43189988-1D206056-C970-4C60-9907-98B35D074D5EQ46871703-C014E18D-0589-48B3-A6C8-7DF4C68B634AQ53602643-6152781D-C0B2-4901-B53D-9AFD2B0FB31B
P2860
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
@en
type
label
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
@en
prefLabel
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
@en
P2860
P50
P1476
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
@en
P2093
F Javier Pastor
Montserrat Ortoneda
P2860
P304
P356
10.1128/AAC.47.12.3976-3978.2003
P407
P577
2003-12-01T00:00:00Z